Skip to main content
Prof. Dr. Frank G. Holz – Director of the Department of Ophthalmology at the University Hospital Bonn (UKB) and Professor at the University of Bonn.
© Intuitive Fotografie Köln

News categories: Honors & Funding

Frank Holz Nominated for the Science Breakthrough of the Year 2026

A remarkable achievement for the Faculty of Medicine at the University of Bonn: Prof. Dr. Frank G. Holz, Director of the Department of Ophthalmology at the University Hospital Bonn (UKB) and Professor at the University of Bonn, has been shortlisted for the Falling Walls Science Breakthrough of the Year 2026 in the Life Sciences category. His project is now among the 30 most outstanding scientific innovations worldwide in this category, recognized by the prestigious Falling Walls Science Summit. Being shortlisted alone represents a significant international distinction. The winners in each category will be announced during the Falling Walls Science Summit, taking place in Berlin from November 6–11, 2026.

Prof. Frank Holz, who is also a member of the University of Bonn's ImmunoSensation³ Cluster of Excellence, was shortlisted for his pioneering work on restoring central vision in patients with advanced age-related macular degeneration (AMD). In an international clinical trial led by the Department of Ophthalmology at the University Hospital Bonn (UKB), patients with geographic atrophy, a severe late stage of AMD, were able to partially regain central vision for the first time.

The approach is based on a 2 × 2 mm subretinal microchip implant, which is surgically placed beneath the central retina. The implant replaces the function of degenerated, non-functional photoreceptors and, in combination with specialized camera-equipped glasses, converts incoming infrared light into electrical signals. More than 80 percent of participants experienced significant improvements in visual acuity, while over 84 percent were once again able to recognize letters, numbers, or words following implantation. The study results were published in the New England Journal of Medicine.

"Having our work recognized as one of the world's outstanding scientific breakthroughs of the year is a tremendous honor for the entire interdisciplinary team behind this project," says Prof. Frank G. Holz. "For many people with advanced macular degeneration, this technology offers genuine new hope. Seeing fundamental research and clinical innovation come together so closely - from the initial idea all the way to benefiting patients - is what motivates us and demonstrates the enormous potential of translational research."

Translating Scientific Discoveries into Technological Innovation

The nomination highlights the strong commitment of the University of Bonn and the University Hospital Bonn to translating scientific discoveries into tangible technological innovations. At the University of Bonn, the Transfer Center enaCom, together with the Technology Transfer Team of the Faculty of Medicine, supports researchers in preparing their scientific findings for practical application. Particularly in medicine, excellent basic research can directly benefit patients by enabling the development of innovative treatment strategies.

"Prof. Holz's work is exceptional both in its scientific excellence and its clinical impact," says Prof. Dr. Bernd Weber, Dean of the Faculty of Medicine at the University of Bonn. "Being shortlisted for the Science Breakthroughs of the Year is a tremendous recognition of this approach. I warmly congratulate Prof. Holz and his entire team on this outstanding achievement."

The award is presented annually by the Falling Walls Foundation, which is supported, among others, by the German Federal Ministry of Research, Technology and Space (BMFTR). The Foundation brings together science, business, politics, the arts, and society to shape the future through impactful ideas.

 

 

Contact
Prof. Dr. Frank Holz
Department of Ophthalmology
Venusberg-Campus 1, 53127 Bonn
E-mail: frank.holz@ukb.uni-bonn.de
Phone: +49 228 28715647

Related news

With funding from the Corona Foundation, Dr Christina Mayer (right) is establishing her own junior research group and developing the field of neurovisual diagnostics at the Department of Neurology at UKB, headed by Prof Anne-Katrin Pröbstel (left).

News categories: Honors & Funding

The Retina as a Window into the Early Detection of Brain Diseases

—The retina is the only part of the central nervous system that can be examined non-invasively and at high resolution in living humans. Dr Christina Mayer and her team at Bonn University Hospital (UKB) and the University of Bonn aim to use this unique feature to detect inflammatory and vascular diseases of the brain earlier and more accurately, and to better understand how they develop. The Corona Foundation is providing €1 million to establish her junior research group. The programme gives outstanding early-career researchers the opportunity to qualify for a university professorship.
View entry
Prof. Joanna Kalucka joins Bonn as a Mercator Fellow and investigates how metabolic and inflammatory processes affect the inner lining of blood vessels.

News categories: Honors & Funding

Joanna Kalucka Joins Bonn as a Mercator Fellow

—Joanna Kalucka, Associate Professor at Aarhus University’s Department of Biomedicine, will join the Collaborative Research Centre (CRC) 1454 “Metaflammation and Cellular Programming” at the University of Bonn and Bonn University Hospital (UKB) as a Mercator Fellow Global from 2027. The German Research Foundation (DFG) is funding her fellowship through the “1000 Heads Plus” programme of the Federal Ministry of Research, Technology and Space (BMFTR).
View entry
Prof. Christian Henneberger, Direktor des Instituts für Zelluläre Neurowissenschaften I am UKB, und Prof. Susanne Schoch McGovern,
Prof. Christian Henneberger, Direktor des Instituts für Zelluläre Neurowissenschaften I am UKB, und Prof. Susanne Schoch McGovern, - Direktorin des Instituts für Zelluläre Neurowissenschaften II am UKB, sind Sprecher und stellvertretende Sprecherin der neuen DFG-Forschungsgruppe FOR 5987. Der Forschungsverbund untersucht, wie Botenstoffe Informationen im Gehirn innerhalb und außerhalb von Synapsen übertragen.

News categories: Honors & Funding

How Far Do Signalling Molecules Act Beyond the Boundaries of a Synapse?

—The German Research Foundation (DFG) is establishing a new Research Unit entitled “Inside and Outside the Synapse: Challenging Dogmas of Synaptic Signalling and Neuromodulation.” The research consortium is headed by Prof. Christian Henneberger from Bonn University Hospital (UKB) and the University of Bonn, with Prof. Susanne Schoch McGovern, also from the UKB and the University of Bonn. Together with researchers from the UKB, the University of Bonn, the DZNE and the University of Göttingen, they will investigate how signalling molecules transmit information in the brain.
View entry

Back to the news overview